Vivos Therapeutics to present at Small Cap Showcase on June 9
Vivos Therapeutics announced participation in The Small Cap Showcase & WTR Insights on June 9, 2026, in New York City. CEO Kirk Hunstman will present at 11:30 am ET and hold investor meetings. A live webcast and replay will be accessible.
*this image is generated using AI for illustrative purposes only.
Vivos Therapeutics, Inc. announced that members of its executive management team will participate in The Small Cap Showcase & WTR Insights on June 9, 2026, in New York City. The event serves as a forum for the company to engage with investors and showcase its medical device and healthcare services focused on treating breathing-related sleep disorders.
Kirk Hunstman, CEO of Vivos Therapeutics, is scheduled to deliver a corporate presentation at 11:30 am ET. He will also participate in one-on-one meetings with pre-qualified investors throughout the day.
The Small Cap Showcase & WTR Insights brings together management teams from approximately 20 micro and small-cap companies across various industries. The event aims to facilitate discovery of investment opportunities through presentations, industry insights, and networking.
Access to the presentation details is outlined below:
| Event Detail | Information |
|---|---|
| Event Name | The Small Cap Showcase & WTR Insights |
| Date | June 9, 2026 |
| Location | New York City |
| Presenter | Kirk Hunstman, CEO |
| Presentation Time | 11:30 am ET |
A live webcast of the presentation will be available online. A replay will be accessible following the event through the Investor Relations section of the Vivos Therapeutics website.
Vivos Therapeutics focuses on developing diagnostic and treatment methods for patients with obstructive sleep apnea (OSA) and snoring. The company's Complete Airway Repositioning and Expansion (CARE) devices are cleared by the U.S. Food and Drug Administration (FDA) for adult patients with all severity levels of OSA and for moderate-to-severe OSA in children ages 6 to 17.
What key growth metrics or clinical data milestones does Vivos plan to highlight during the presentation to attract new investors?
How does Vivos intend to leverage the one-on-one meetings to secure strategic partnerships or funding for future expansion?
What potential market impact could this investor showcase have on Vivos' stock liquidity and analyst coverage in the coming months?
20
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
